Phosphorylation: a molecular switch in opioid tolerance

Zaijie Jim Wang1, Lili X Wang

  • 1Department of Biopharmaceutical Sciences and Cancer Center, University of Illinois, Chicago, IL 60612, USA. zjwang@uic.edu

Life Sciences
|July 13, 2006
PubMed

Insights

Protein phosphorylation by kinases like PKC and PKA is crucial for opioid tolerance. Targeting these kinases may help improve pain relief by reducing tolerance to opioids.

Area of Science:

  • Biochemistry
  • Neuroscience
  • Pharmacology

Background:

  • Protein phosphorylation is a critical posttranslational modification regulating protein function.
  • Opioid tolerance, a major clinical challenge, is increasingly linked to specific kinase pathways.

Purpose of the Study:

  • To review recent findings on the role of major protein kinases in opioid tolerance.
  • To highlight the potential of targeting these kinases for improved opioid analgesia.

Main Methods:

  • Literature review of studies investigating protein kinases and opioid tolerance.
  • Focus on protein kinase C (PKC), PKA, CaMKII, PKG, and GRK.

Main Results:

  • Several protein kinases, including PKC, PKA, CaMKII, PKG, and GRK, are implicated in promoting and maintaining opioid tolerance.
  • These kinases function as molecular switches regulating the development of tolerance.

Conclusions:

  • Protein kinase activity is central to the mechanisms underlying opioid tolerance.
  • Pharmacological targeting of these kinases and phosphatases offers a promising strategy to enhance opioid efficacy and manage pain.

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Phosphorylation01:02

Phosphorylation

The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...